| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
6e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
| mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |